Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus

Pioglitazone Decreases Plasma Angiotensin II Concentration inType 2 Diabetes

(2011) Atsuhito Saiki et al.   Journal of Atherosclerosis and Thrombosis

Atrial Substrate Properties and Outcome of Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation Associated With Diabetes Mellitus or Impaired Fasting Glucose

(2010) Tze-Fan Chao et al.   AMERICAN JOURNAL OF CARDIOLOGY

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on the Long-Term Outcome after Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation

(2010) Hanno U. Klemm et al.   CARDIOLOGY

Pioglitazone-Induced Reductions in Atherosclerosis Occur via Smooth Muscle Cell–Specific Interaction With PPARγ

(2010) Venkateswaran Subramanian et al.   CIRCULATION RESEARCH

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats

(2010) Osamu Kume et al.   HEART RHYTHM

Prevention of Atrial Fibrillation Recurrence With Corticosteroids After Radiofrequency Catheter Ablation

(2010) Takashi Koyama et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Very Late Relapse of Atrial Fibrillation after Pulmonary Vein Isolation: Incidence and Results of Repeat Ablation

(2010) STEPHANIE FICHTNER et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Comparison of Characteristics and Significance of Immediate Versus Early Versus No Recurrence of Atrial Fibrillation After Catheter Ablation

(2009) Takashi Koyama et al.   AMERICAN JOURNAL OF CARDIOLOGY

Downregulation of Peroxisome Proliferator-activated Receptor-γ Expression in Hypertensive Atrial Fibrillation

(2009) Xiaoping Chen et al.   CLINICAL CARDIOLOGY

Pioglitazone improves superoxide dismutase mediated vascular reactivity in the obese Zucker rat

(2009) Amir H. Dorafshar et al.   Diabetes & Vascular Disease Research

Does inflammation influence atrial fibrillation recurrence following catheter ablation?

(2009) A. Kourliouros et al.   EUROPACE

Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation

(2009) Masayuki Shimano et al.   HEART RHYTHM

Current concepts in the pathogenesis of atrial fibrillation

(2008) Antonios Kourliouros et al.   AMERICAN HEART JOURNAL

TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis

(2008) Kazuo Fujisawa et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Pulmonary vein isolation combined with superior vena cava isolation for atrial fibrillation ablation: a prospective randomized study

(2008) X.-H. Wang et al.   EUROPACE

Acute and Chronic Pulmonary Vein Reconnection after Atrial Fibrillation Ablation: A Prospective Characterization of Anatomical Sites

(2008) KIM RAJAPPAN et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure

(2007) Masayuki Shimano et al.   HEART RHYTHM